Displaying 1681 - 1710 of 2473
Project 'Digital technology and social participation in surveillance and definition of priority areas and actions for the control of yellow fever in Brazil' is the result of a partnership between Fiocruz, the Ministry of Health, the Health Department of P
Genomic Network points to an increase of the BA.2 lineage. Data show that the Omicron variant has completely replaced Delta in Brazil
Study demonstrates that even people previously infected with Sars-CoV-2 have increased levels of protection when vaccinated
In addition to the Memorandum of Understanding focused on dengue fever, a Strategic Research Alliance was also established between the institutions and the joint submission of a project for Neglected Diseases
Em artigo na revista Dados, pesquisadores da COC/Fiocruz apontam que experiências como a do sociólogo rural Lynn Smith no Brasil foram na contramão da leitura difusionista da história das ciências
Plataforma Institucional Biodiversidade e Saúde Silvestre da Fiocruz premiou (29/3) os 10+ Colaboradores do Siss-Geo em 2021, para reconher participação da sociedade e de órgãos e unidades da saúde, ambiente e outros no monitoramento de animais silvestres
Implementation of a World Health Organization hub for Pandemic and Epidemiological Intelligence led WHO to organize the visit of a high delegation, together with PAHO, to Fiocruz
Representatives of Fiocruz and members of the US Consulate General, in Rio de Janeiro, continued the partnership process started in 2021
Todos os 26 estados, o Distrito Federal e os 5.570 municípios brasileiros são chamados a participar da pesquisa '(Re)Conhecer para Fortalecer a Auditoria do SUS: SNA em foco', lançada nesta segunda-feira (28/3) na Fiocruz Brasília
The Institute of Technology in Immunobiologicals (Bio-Manguinhos/Fiocruz) will be the Brazilian representative at the Brics Center for Vaccine Research and Development, with the aim of sharing experiences, information and training
Representatives of Fiocruz and DFG, a German non-profit organization that supports research, met to strengthen bilateral cooperation between the institutions
Researchers from Fiocruz and Columbia University combined antiviral drugs that showed that together they can reduce the replication of Sars-CoV-2
With six injections per year, the method has proven to be more effective than daily oral PrEP in terms of reducing the risk of infection
Diseases transmitted from animals to humans present early clinical symptoms similar to those of other infections. The delayed identification increases the risk of severe disease and death